Delivery Order SPE2DR25D1002-SPE2DR26FGH8Y
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,944.44 for LYUMJEV 100 Unit/mL vials (10mL) on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction supporting federal...
- The Defense Logistics Agency awarded a $1,013.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for Lyumjev 100 Unit/mL vials (10 mL units) on September 23, 2025, with an ultimate completion date of September 24, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- This federal contract award is for the delivery of LYUMJEV 100 UNIT/ML VIAL 10ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,291.63 Firm Fixed Price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 5, 2024 with a performance period ending on August 6, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,773.57, is for the delivery of LYUMJEV 100 UNIT/ML VIAL 10ML, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 5, 2023. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and holds a significant...
- The Defense Logistics Agency Troop Support Medical awarded a $450,270 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561411499 LYUMJEV 100 UNIT/ML VIAL 10ML. The place of performance is Conshohocken, Pennsylvania. The period of performance is July 5-6, 2023. This delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of the Defense Logistics Agency's medical logistics programs. No...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LYUMJEV 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract has a firm fixed price of $1,013.45 and a completion date of February 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical,...
- This is a $2,505.41 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, to provide Lyumjev 100 unit/mL KwikPen 3mL, a prescription insulin product. The contract has a firm fixed price and a completion date of April 26, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,116.13 firm fixed-price delivery order is for the supply of LYUMJEV 100 UNIT/ML VIAL 10ML, a pharmaceutical product, with a period of performance through April 23, 2024. Amerisourcebergen Drug Corporation holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred fifty dollars and nine cents to Amerisourcebergen Drug Corporation for LYUMJEV 100 unit/ml vials. As the prime contractor, Amerisourcebergen Drug Corporation will deliver ten milliliters of the diabetes medication in vials to a location in Conshohocken, Pennsylvania by July 24, 2023 to fulfill requirements under the Agency's pharmaceutical supply chain program. The order was funded by the Defense...
- The Defense Logistics Agency Troop Support Medical awarded a $1,276 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 100 unit/ml vials of LYUMJEV insulin. The delivery order was issued against an undisclosed governmentwide acquisition contract vehicle and calls for 10 ml of the specified pharmaceutical product. Performance will take place at the prime contractor's facility located in Conshohocken, Pennsylvania over a one day period from October 3 to...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGH8YDelivery Order
The Defense Logistics Agency awarded a $2,102.00 delivery order to AmerisourceBergen Drug Corp for Lyumjev 100 Unit/mL vials (10 mL) under a firm fixed-price contract. The award, issued on October 22, 2025, with an ultimate completion date of October 23, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The contract supports customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/22/25 |